Organogenesis Ownership 2024 | Who Owns Organogenesis Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

47.49%

Insider Ownership

32.88%

Retail Ownership

19.63%

Institutional Holders

116.00

Organogenesis Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
MORGAN STANLEY8.78%0.00%11,576,05948,0310.42%32,412,966Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.8.74%2.84%11,518,9541,945,75620.32%32,253,071Jun 30, 2024
BLACKROCK INC.3.86%0.00%5,087,146112,8452.27%14,244,008Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.3.02%0.02%3,977,1243,005,450309.31%11,135,947Jun 30, 2024
VANGUARD GROUP INC2.70%0.00%3,562,71027,4110.78%9,975,589Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC2.33%0.03%3,074,37572,6962.42%8,605,000Jun 30, 2024
DEUTSCHE BANK AG\1.90%0.00%2,504,059-6,146-0.24%7,011,365Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC1.72%0.01%2,268,760986,13276.88%6,352,528Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP1.54%0.00%2,036,743333,12319.55%5,701,649Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC1.32%0.00%1,746,894-1,629-0.09%4,891,852Jun 30, 2024
STATE STREET CORP1.10%0.00%1,450,677-1,117-0.08%4,061,896,000Jun 30, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.70%0.00%924,77614,0371.54%2,589,373Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.67%0.17%884,721353,50366.55%2,477,000Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC0.60%0.00%795,700-11,400-1.41%2,227,960Jun 30, 2024
D. E. SHAW & CO., INC.0.56%0.00%741,933109,18917.26%2,077,413Jun 30, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND0.49%0.01%649,900--1,819,720Jun 30, 2024
NORTHERN TRUST CORP0.45%0.00%588,995-27,594-4.48%1,649,186,000Jun 30, 2024
BANK OF AMERICA CORP /DE/0.38%0.00%496,54011,6432.40%1,390,312Jun 30, 2024
NORGES BANK0.37%0.00%482,200482,200100.00%1,350,160Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.34%0.01%446,36219,1584.48%1,249,814Jun 30, 2024

Organogenesis's largest institutional shareholder is MORGAN STANLEY, holding 8.78% of the company's total share outstanding, currently valued at $32.41M. The top 10 institutional shareholders own together 35.91% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
SOLEUS CAPITAL MANAGEMENT, L.P.8.74%2.84%11,518,9541,945,75620.32%32,253,071Jun 30, 2024
WEALTH DIMENSIONS GROUP, LTD.0.31%0.33%407,965331,840435.91%1,142,302Jun 30, 2024
ADVANTAGE ALPHA CAPITAL PARTNERS LP0.27%0.22%358,454-37,662-9.51%1,003,671Jun 30, 2024
KENT LAKE CAPITAL LLC0.12%0.19%151,905151,905100.00%425,334Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.67%0.17%884,721353,50366.55%2,477,000Jun 30, 2024
AJOVISTA, LLC0.01%0.13%15,51315,513100.00%43,436Jun 30, 2024
SENTINEL TRUST CO LBA0.11%0.05%149,035--417,000Jun 30, 2024
STATE OF WYOMING0.07%0.04%95,0076,3027.10%266,020Jun 30, 2024
CAPITAL SQUARE, LLC0.02%0.04%20,300500.25%61,306Jun 30, 2024
STONERIDGE INVESTMENT PARTNERS LLC0.03%0.04%34,105--95,000Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC2.33%0.03%3,074,37572,6962.42%8,605,000Jun 30, 2024
ASSENAGON ASSET MANAGEMENT S.A.3.02%0.02%3,977,1243,005,450309.31%11,135,947Jun 30, 2024
CONNORS INVESTOR SERVICES INC0.05%0.02%70,0002,0002.94%196,000Jun 30, 2024
DELAP WEALTH ADVISORY, LLC0.01%0.02%14,23414,234100.00%39,855Jun 30, 2024
WINTON GROUP LTD0.05%0.01%61,066-4,139-6.35%170,985Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC1.72%0.01%2,268,760986,13276.88%6,352,528Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.01%5,7005,700100.00%15,960Jun 30, 2024
TRIVANT CUSTOM PORTFOLIO GROUP, LLC0.00%0.01%5,4521,70245.39%15,266Jun 30, 2024
SUSQUEHANNA PORTFOLIO STRATEGIES, LLC0.05%0.01%69,238-8,036-10.40%193,866Jun 30, 2024
POINT72 ASIA (SINGAPORE) PTE. LTD.0.01%0.01%11,400-1,234-9.77%31,921Jun 30, 2024

The largest Organogenesis shareholder by % of total assets is SOLEUS CAPITAL MANAGEMENT, L.P.. The company owns 11.52M shares of Organogenesis (ORGO), representing 2.84% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ASSENAGON ASSET MANAGEMENT S.A.3.02%0.02%3,977,1243,005,450309.31%11,135,947Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.8.74%2.84%11,518,9541,945,75620.32%32,253,071Jun 30, 2024
AQR CAPITAL MANAGEMENT LLC1.72%0.01%2,268,760986,13276.88%6,352,528Jun 30, 2024
NORGES BANK0.37%0.00%482,200482,200100.00%1,350,160Jun 30, 2024
GSA CAPITAL PARTNERS LLP0.67%0.17%884,721353,50366.55%2,477,000Jun 30, 2024
DIMENSIONAL FUND ADVISORS LP1.54%0.00%2,036,743333,12319.55%5,701,649Jun 30, 2024
WEALTH DIMENSIONS GROUP, LTD.0.31%0.33%407,965331,840435.91%1,142,302Jun 30, 2024
JACOBS LEVY EQUITY MANAGEMENT, INC0.33%0.01%429,804243,568130.78%1,203,451Jun 30, 2024
KENT LAKE CAPITAL LLC0.12%0.19%151,905151,905100.00%425,334Jun 30, 2024
BLACKROCK INC.3.86%0.00%5,087,146112,8452.27%14,244,008Jun 30, 2024
D. E. SHAW & CO., INC.0.56%0.00%741,933109,18917.26%2,077,413Jun 30, 2024
CUBIST SYSTEMATIC STRATEGIES, LLC0.07%0.00%94,70588,1751350.31%265,173Jun 30, 2024
ACADIAN ASSET MANAGEMENT LLC2.33%0.03%3,074,37572,6962.42%8,605,000Jun 30, 2024
GOLDMAN SACHS GROUP INC0.19%0.00%247,95061,08332.69%694,260Jun 30, 2024
MORGAN STANLEY8.78%0.00%11,576,05948,0310.42%32,412,966Jun 30, 2024
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO0.04%0.00%58,12846,145385.09%162,758Jun 30, 2024
SAVANT CAPITAL, LLC0.03%0.00%44,90844,908100.00%125,743Jun 30, 2024
FMR LLC0.10%-129,39644,74452.86%362,309Jun 30, 2024
INVESCO LTD.0.20%0.00%267,14743,80019.61%748,011Jun 30, 2024
SQUAREPOINT OPS LLC0.07%0.00%91,03440,71080.90%254,895Jun 30, 2024

As of Jun 30 2024, Organogenesis's largest institutional buyer is ASSENAGON ASSET MANAGEMENT S.A.. The company purchased 3.01M stocks of ORGO, valued at $11.14M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
THOMPSON SIEGEL & WALMSLEY LLC----429,182-100.00%-Jun 30, 2024
HRT FINANCIAL LP----318,943-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----229,300-100.00%-Jun 30, 2024
AMERIPRISE FINANCIAL INC0.10%0.00%132,467-223,984-62.84%370,908Jun 30, 2024
TWO SIGMA INVESTMENTS, LP0.20%0.00%267,405-202,445-43.09%748,734Jun 30, 2024
LOS ANGELES CAPITAL MANAGEMENT LLC0.28%0.00%368,591-131,976-26.37%1,032,055Jun 30, 2024
DIVISADERO STREET CAPITAL MANAGEMENT, LP----100,000-100.00%-Jun 30, 2024
AMERICAN CENTURY COMPANIES INC0.10%0.00%130,259-97,626-42.84%364,725Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD0.00%-2,170-79,033-97.33%6,076Jun 30, 2024
MILLENNIUM MANAGEMENT LLC0.10%0.00%133,843-76,913-36.49%374,760Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP----73,650-100.00%-Jun 30, 2024
JPMORGAN CHASE & CO0.08%-99,120-67,505-40.51%277,535Jun 30, 2024
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC0.01%0.00%18,435-54,494-74.72%51,618Jun 30, 2024
OCCUDO QUANTITATIVE STRATEGIES LP----52,426-100.00%-Jun 30, 2024
DENALI ADVISORS LLC----45,500-100.00%-Jun 30, 2024
XTX TOPCO LTD----43,584-100.00%-Jun 30, 2024
BAILARD, INC.----40,400-100.00%-Jun 30, 2024
GLOBEFLEX CAPITAL L P----39,043-100.00%-Jun 30, 2024
ADVANTAGE ALPHA CAPITAL PARTNERS LP0.27%0.22%358,454-37,662-9.51%1,003,671Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----34,619-100.00%-Jun 30, 2024

As of Jun 30 2024, Organogenesis's biggest institutional seller is THOMPSON SIEGEL & WALMSLEY LLC. The company sold -0.43M shares of ORGO, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORGES BANK0.37%0.00%482,200482,200100.00%1,350,160Jun 30, 2024
KENT LAKE CAPITAL LLC0.12%0.19%151,905151,905100.00%425,334Jun 30, 2024
SAVANT CAPITAL, LLC0.03%0.00%44,90844,908100.00%125,743Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.03%0.00%38,83638,836100.00%108,741Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.03%0.00%35,79435,794100.00%100,223Jun 30, 2024
CERITY PARTNERS LLC0.02%0.00%29,95429,954100.00%83,872Jun 30, 2024
AJOVISTA, LLC0.01%0.13%15,51315,513100.00%43,436Jun 30, 2024
O'SHAUGHNESSY ASSET MANAGEMENT, LLC0.01%0.00%14,51514,515100.00%40,642Jun 30, 2024
DELAP WEALTH ADVISORY, LLC0.01%0.02%14,23414,234100.00%39,855Jun 30, 2024
PALLAS CAPITAL ADVISORS LLC0.01%0.00%12,77512,775100.00%37,559Jun 30, 2024
AVANTAX PLANNING PARTNERS, INC.0.01%0.00%10,32410,324100.00%28,907Jun 30, 2024
INNEALTA CAPITAL, LLC0.01%0.01%6,8506,850100.00%19,180Jun 30, 2024
NVERSES CAPITAL, LLC0.00%0.01%5,7005,700100.00%15,960Jun 30, 2024
SRS CAPITAL ADVISORS, INC.0.00%0.00%2,3112,311100.00%6,471Jun 30, 2024
SIMPLEX TRADING, LLC0.00%-1,8231,823100.00%5,000Jun 30, 2024
LINDBROOK CAPITAL, LLC0.00%0.00%781781100.00%2,187Jun 30, 2024

Organogenesis's largest new institutional shareholder by number of shares is NORGES BANK, purchased 482.20K shares, valued at $1.35M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
THOMPSON SIEGEL & WALMSLEY LLC----429,182-100.00%-Jun 30, 2024
HRT FINANCIAL LP----318,943-100.00%-Jun 30, 2024
STATE OF WISCONSIN INVESTMENT BOARD----229,300-100.00%-Jun 30, 2024
DIVISADERO STREET CAPITAL MANAGEMENT, LP----100,000-100.00%-Jun 30, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP----73,650-100.00%-Jun 30, 2024
OCCUDO QUANTITATIVE STRATEGIES LP----52,426-100.00%-Jun 30, 2024
DENALI ADVISORS LLC----45,500-100.00%-Jun 30, 2024
XTX TOPCO LTD----43,584-100.00%-Jun 30, 2024
BAILARD, INC.----40,400-100.00%-Jun 30, 2024
GLOBEFLEX CAPITAL L P----39,043-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----34,619-100.00%-Jun 30, 2024
CAXTON ASSOCIATES LP----31,074-100.00%-Jun 30, 2024
OXFORD ASSET MANAGEMENT LLP----22,631-100.00%-Jun 30, 2024
SG AMERICAS SECURITIES, LLC----21,565-100.00%-Jun 30, 2024
VIRTU FINANCIAL LLC----19,536-100.00%-Jun 30, 2024
MARSHALL WACE, LLP----15,114-100.00%-Jun 30, 2024
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.----15,000-100.00%-Jun 30, 2024
PROSHARE ADVISORS LLC----12,620-100.00%-Jun 30, 2024
POINT72 (DIFC) LTD----4,585-100.00%-Jun 30, 2024
METROPOLITAN LIFE INSURANCE CO/NY----1,630-100.00%-Jun 30, 2024
BARRETT & COMPANY, INC.----1,100-100.00%-Jun 30, 2024
OLD POINT TRUST & FINANCIAL SERVICES N A----250-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----13-100.00%-Jun 30, 2024
ASSETMARK, INC----4-100.00%-Jun 30, 2024

Organogenesis's largest sold out institutional shareholder by shares sold is THOMPSON SIEGEL & WALMSLEY LLC, sold -0.43M shares, valued at -, as of undefined.

Organogenesis Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
SYNTAX ETF TRUST0.67%21,123--Mar 31, 2024
OBERWEIS FUNDS0.36%368,408--Mar 31, 2024
VANGUARD ADMIRAL FUNDS0.13%546,367--Feb 29, 2024
Humankind Benefit Corp0.10%2,234--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.10%51,218--Mar 31, 2024
BNY MELLON INDEX FUNDS, INC.0.09%97,546--Jan 31, 2024
BNY MELLON INVESTMENT PORTFOLIOS0.07%43,175--Mar 31, 2024
Vericimetry Funds0.05%4,790--Mar 31, 2024
BlackRock Advantage SMID Cap Fund, Inc.0.05%9,237--Mar 28, 2024
Gabelli Healthcare & WellnessRx Trust0.04%5,200--Dec 29, 2023
Federated Hermes MDT Series0.04%90,300--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED ALPHADEX FUND0.03%118,322--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.03%88,1941,4261.64%Feb 29, 2024
Lattice Strategies Trust0.03%39,22626,089198.59%Mar 31, 2024
HOTCHKIS & WILEY FUNDS /DE/0.02%277,300--Mar 31, 2024
BNY Mellon Strategic Funds, Inc.0.02%48,179--Mar 31, 2024
QUANTITATIVE MASTER SERIES LLC0.02%128,915--Mar 31, 2024
GABELLI EQUITY TRUST INC0.02%24,375--Dec 29, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.02%10,819--Mar 31, 2024
FORUM FUNDS II0.01%12,252--Jan 31, 2024
Securian Funds Trust0.01%122,809--Mar 31, 2024
Ivy Variable Insurance Portfolios0.01%263,420--Mar 28, 2024
FINANCIAL INVESTORS TRUST0.01%915,940--Jan 31, 2024
SCHWAB CAPITAL TRUST0.01%455,375--Jan 31, 2024
Destra Investment Trust0.01%17,371--Mar 31, 2024
VANGUARD EXPLORER FUND0.01%126,114--Jan 31, 2024
IndexIQ ETF Trust0.01%23,178--Jan 31, 2024
Legg Mason ETF Investment Trust0.01%17,968--Mar 31, 2024
HUSSMAN INVESTMENT TRUST0.01%31,000--Dec 31, 2023
VANGUARD QUANTITATIVE FUNDS0.01%40,100--Mar 31, 2024
Fidelity Commonwealth Trust II0.01%52,81231,912152.69%Aug 31, 2023
ALPS ETF Trust0.01%82,731--Feb 29, 2024
GPS Funds I0.01%35,513-4,613-11.50%Mar 31, 2024
VANGUARD INDEX FUNDS0.01%2,652,852-2,907,057-52.29%Mar 31, 2024
NEXPOINT FUNDS I0.01%20,000--Dec 31, 2023
IVY FUNDS0.00%1,670,726--Mar 28, 2024
TIAA SEPARATE ACCOUNT VA 10.00%1,103--Mar 31, 2024
VANGUARD HORIZON FUNDS0.00%116,256--Mar 31, 2024
INVESCO EXCHANGE-TRADED FUND TRUST0.00%405,721--Jan 31, 2024
FIDELITY CONCORD STREET TRUST0.00%722,13927,5183.96%Feb 29, 2024
TARGET PORTFOLIO TRUST0.00%69,400--Jan 31, 2024
MFS VARIABLE INSURANCE TRUST III0.00%52,889-2,149-3.90%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%34,5406852.02%Mar 31, 2024
FIDELITY COVINGTON TRUST0.00%52,209-603-1.14%Mar 31, 2024
VANGUARD TAX-MANAGED FUNDS0.00%569,981--Mar 31, 2024
BRIDGEWAY FUNDS INC0.00%6,400--Mar 28, 2024
PRUDENTIAL INVESTMENT PORTFOLIOS, INC.0.00%25,650--Mar 28, 2024
Principal Exchange-Traded Funds0.00%26,9372,61210.74%Mar 31, 2024
TIMOTHY PLAN0.00%9,612--Mar 31, 2024
Direxion Shares ETF Trust0.00%310,156--Jan 31, 2024
Calvert Variable Products, Inc.0.00%5,386--Mar 31, 2024
AMERICAN CENTURY ETF TRUST0.00%228,888-30,342-11.70%Feb 29, 2024
SHELTON FUNDS0.00%3,226--Feb 29, 2024
STEWARD FUNDS, INC.0.00%4,190--Jan 31, 2024
Federated Hermes Adviser Series0.00%10,216--Mar 31, 2024
BMO FUNDS, INC.0.00%62,03124,08763.48%Nov 30, 2021
Catholic Responsible Investments Funds0.00%52,7141,4212.77%Jan 31, 2023
VANGUARD VARIABLE INSURANCE FUNDS0.00%76,37018,63032.27%Mar 31, 2024
Invesco Exchange-Traded Fund Trust II0.00%417,724--Jan 31, 2024
PRAXIS MUTUAL FUNDS0.00%14,360--Dec 31, 2023
CALAMOS INVESTMENT TRUST/IL0.00%129,884--Jan 31, 2024
Dimensional ETF Trust0.00%463,504-33,720-6.78%Jan 31, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%31,293-44,072-58.48%Mar 31, 2024
GOLDMAN SACHS VARIABLE INSURANCE TRUST0.00%4,154--Mar 31, 2024
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%50,846--Dec 31, 2023
PRUDENTIAL SERIES FUND0.00%65,100--Mar 28, 2024
VANGUARD WORLD FUND0.00%201,524-43,406-17.72%Feb 29, 2024
Mutual of America Variable Insurance Portfolios, Inc.0.00%557--Sep 30, 2023
Voya VARIABLE PORTFOLIOS INC0.00%24,041-5,782-19.39%Mar 31, 2024
OHIO NATIONAL FUND INC0.00%14,662--Mar 31, 2024
SCHWAB STRATEGIC TRUST0.00%389,69913,5703.61%Feb 29, 2024
THRIVENT SERIES FUND INC0.00%72,514--Mar 28, 2024
Goldman Sachs ETF Trust0.00%64,341-2,495-3.73%Feb 29, 2024
Virtus Investment Trust0.00%21,500--Mar 28, 2024
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%3,071-997-24.51%Mar 31, 2024
RBC FUNDS TRUST0.00%70,700--Mar 28, 2024
NORTHERN LIGHTS FUND TRUST II0.00%6,8136,813-Mar 31, 2024
Janus Detroit Street Trust0.00%79,298--Jan 31, 2024
CLEARWATER INVESTMENT TRUST0.00%4,485--Mar 28, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%475,34082,41920.98%Jan 31, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%100,0704,0784.25%Feb 29, 2024
FLEXSHARES TRUST0.00%34,905--Jan 31, 2024
VICTORY PORTFOLIOS0.00%13,690--Mar 31, 2024
TIAA-CREF LIFE FUNDS0.00%1,082--Mar 31, 2024
ADVISORS' INNER CIRCLE FUND0.00%9,536--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%24,098--Mar 31, 2024
MUTUAL OF AMERICA INVESTMENT CORP0.00%14,259--Mar 31, 2024
NATIONWIDE MUTUAL FUNDS0.00%45,26835,902383.32%Jan 31, 2024
SunAmerica Specialty Series0.00%167--Apr 30, 2021
NORTHWESTERN MUTUAL SERIES FUND INC0.00%29,707--Mar 31, 2024
NORTHERN FUNDS0.00%36,416-3,608-9.01%Mar 28, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%33,63113,30065.42%Mar 31, 2024
EQ ADVISORS TRUST0.00%285,908--Mar 31, 2024
FundVantage Trust0.00%3,571--Mar 28, 2024
SEASONS SERIES TRUST0.00%4,981--Mar 31, 2024
T. Rowe Price Index Trust, Inc.0.00%4,54777720.61%Mar 31, 2024
ALLSPRING MASTER TRUST0.00%11,523--Feb 29, 2024
THRIVENT MUTUAL FUNDS0.00%16,358--Mar 28, 2024
LAZARD FUNDS INC0.00%6,406--Mar 31, 2024
iSHARES TRUST0.00%2,561,640-230,930-8.27%Mar 31, 2024

Organogenesis's largest mutual fund holder by % of total assets is "SYNTAX ETF TRUST", owning 21.12K shares, compromising 0.67% of its total assets.

Organogenesis Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24116-7.20%
31 Mar, 2412513.64%
31 Dec, 231101.85%
30 Sep, 23108-6.09%
30 Jun, 23115-12.88%
31 Mar, 23132-11.41%
31 Dec, 221492.05%
30 Sep, 22146-
30 Jun, 22146-7.59%
31 Mar, 22158-1.86%
31 Dec, 211613.87%
30 Sep, 211554.73%
30 Jun, 2114843.69%
31 Mar, 2110353.73%
31 Dec, 206736.73%
30 Sep, 2049-
30 Jun, 2049-3.92%
31 Mar, 2051-7.27%
31 Dec, 195537.50%
30 Sep, 194025.00%
30 Jun, 193252.38%
31 Mar, 19212000.00%
31 Dec, 181-

As of 30 Jun 24, 116 institutions are holding Organogenesis's shares, representing a decrease of -7.20% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2462,622,17310.81%
31 Mar, 2456,511,096-2.87%
31 Dec, 2358,178,34411.66%
30 Sep, 2352,101,4450.61%
30 Jun, 2351,787,769-2.90%
31 Mar, 2353,332,849-4.52%
31 Dec, 2255,858,3231.94%
30 Sep, 2254,792,722-5.62%
30 Jun, 2258,055,4720.19%
31 Mar, 2257,942,9993.80%
31 Dec, 2155,821,6164.45%
30 Sep, 2153,444,2706.96%
30 Jun, 2149,968,092100.88%
31 Mar, 2124,874,77816.54%
31 Dec, 2021,345,179328.38%
30 Sep, 204,982,72113.62%
30 Jun, 204,385,38813.82%
31 Mar, 203,852,948-5.23%
31 Dec, 194,065,684114.07%
30 Sep, 191,899,22519.35%
30 Jun, 191,591,36094.72%
31 Mar, 19817,244-
31 Dec, 18--

Organogenesis (ORGO) has 62.62M shares outstanding as of 30 Jun 24, up 10.81% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2447.49%2.55%
31 Mar, 2443.17%2.20%
31 Dec, 2344.31%2.81%
30 Sep, 2339.68%2.54%
30 Jun, 2339.51%2.39%
31 Mar, 2340.69%2.21%
31 Dec, 2242.94%2.45%
30 Sep, 2241.86%2.09%
30 Jun, 2244.78%2.21%
31 Mar, 2244.99%2.38%
31 Dec, 2143.50%2.52%
30 Sep, 2141.58%2.74%
30 Jun, 2138.97%10.30%
31 Mar, 2119.45%4.96%
31 Dec, 2019.81%88.05%
30 Sep, 204.74%27.05%
30 Jun, 204.19%30.80%
31 Mar, 203.69%21.32%
31 Dec, 194.16%98.17%
30 Sep, 192.06%66.78%
30 Jun, 191.76%215.78%
31 Mar, 190.90%-
31 Dec, 18--

As of 30 Jun 24, Organogenesis is held by 47.49% institutional shareholders, representing a 2.55% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 247110.94%
31 Mar, 246418.52%
31 Dec, 235412.50%
30 Sep, 2348-4.00%
30 Jun, 2350-27.54%
31 Mar, 2369-13.75%
31 Dec, 2280-15.79%
30 Sep, 229523.38%
30 Jun, 2277-16.30%
31 Mar, 2292-8.91%
31 Dec, 2110110.99%
30 Sep, 2191-21.55%
30 Jun, 2111652.63%
31 Mar, 217638.18%
31 Dec, 2055161.90%
30 Sep, 2021-27.59%
30 Jun, 20297.41%
31 Mar, 2027-34.15%
31 Dec, 194186.36%
30 Sep, 1922-
30 Jun, 192210.00%
31 Mar, 19201900.00%
31 Dec, 181-

71 institutional shareholders have increased their position in ORGO stock as of 30 Jun 24 compared to 64 in the previous quarter (a 10.94% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 2430-31.82%
31 Mar, 244422.22%
31 Dec, 2336-2.70%
30 Sep, 2337-11.90%
30 Jun, 23422.44%
31 Mar, 2341-12.77%
31 Dec, 224751.61%
30 Sep, 2231-34.04%
30 Jun, 22474.44%
31 Mar, 224525.00%
31 Dec, 2136-7.69%
30 Sep, 213995.00%
30 Jun, 212011.11%
31 Mar, 2118350.00%
31 Dec, 204-78.95%
30 Sep, 2019111.11%
30 Jun, 209-25.00%
31 Mar, 2012300.00%
31 Dec, 193-62.50%
30 Sep, 19833.33%
30 Jun, 196-
31 Mar, 19--
31 Dec, 18--

30 institutional shareholders have reduced their position in ORGO stock as of 30 Jun 24 compared to 44 in the previous quarter (a -31.82% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24116-7.20%62,622,17310.81%47.49%2.55%7110.94%30-31.82%
31 Mar, 2412513.64%56,511,096-2.87%43.17%2.20%6418.52%4422.22%
31 Dec, 231101.85%58,178,34411.66%44.31%2.81%5412.50%36-2.70%
30 Sep, 23108-6.09%52,101,4450.61%39.68%2.54%48-4.00%37-11.90%
30 Jun, 23115-12.88%51,787,769-2.90%39.51%2.39%50-27.54%422.44%
31 Mar, 23132-11.41%53,332,849-4.52%40.69%2.21%69-13.75%41-12.77%
31 Dec, 221492.05%55,858,3231.94%42.94%2.45%80-15.79%4751.61%
30 Sep, 22146-54,792,722-5.62%41.86%2.09%9523.38%31-34.04%
30 Jun, 22146-7.59%58,055,4720.19%44.78%2.21%77-16.30%474.44%
31 Mar, 22158-1.86%57,942,9993.80%44.99%2.38%92-8.91%4525.00%
31 Dec, 211613.87%55,821,6164.45%43.50%2.52%10110.99%36-7.69%
30 Sep, 211554.73%53,444,2706.96%41.58%2.74%91-21.55%3995.00%
30 Jun, 2114843.69%49,968,092100.88%38.97%10.30%11652.63%2011.11%
31 Mar, 2110353.73%24,874,77816.54%19.45%4.96%7638.18%18350.00%
31 Dec, 206736.73%21,345,179328.38%19.81%88.05%55161.90%4-78.95%
30 Sep, 2049-4,982,72113.62%4.74%27.05%21-27.59%19111.11%
30 Jun, 2049-3.92%4,385,38813.82%4.19%30.80%297.41%9-25.00%
31 Mar, 2051-7.27%3,852,948-5.23%3.69%21.32%27-34.15%12300.00%
31 Dec, 195537.50%4,065,684114.07%4.16%98.17%4186.36%3-62.50%
30 Sep, 194025.00%1,899,22519.35%2.06%66.78%22-833.33%
30 Jun, 193252.38%1,591,36094.72%1.76%215.78%2210.00%6-
31 Mar, 19212000.00%817,244-0.90%-201900.00%--
31 Dec, 181-----1---

Organogenesis Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 18, 2024Cavorsi Robertofficer Vice President, StrategyF-InKindSell317$3.09$979.53139,766
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---57,434
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---51,750
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---23,579
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---4,203
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---2,163
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---739
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---215
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell6,519$15.63$101.89K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell32,559$14.45$470.48K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell19,935$8.03$160.08K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell81,000$2.51$203.31K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell103,842$3.43$356.18K-
Apr 03, 2024Bilbo Patrickofficer Chief Operating OfficerF-InKindSell2,497$2.80$6.99K809,082
Apr 03, 2024Freedman Loriofficer Chief Admin. and Legal OfficerF-InKindSell1,974$2.80$5.53K469,272
Apr 03, 2024Grow Brianofficer Chief Commercial OfficerF-InKindSell1,977$2.80$5.54K520,809
Apr 03, 2024Montecalvo Antonio S.officer Vice President, Health PolicyF-InKindSell1,752$2.80$4.91K168,268
Apr 03, 2024Gillheeney Gary S.director, officer President and CEOF-InKindSell10,113$2.80$28.32K2,351,949
Mar 29, 2024Bilbo Patrickofficer Chief Operating OfficerM-ExemptSell152,250$1.18$179.66K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Jul 18, 2024Cavorsi Robertofficer Vice President, StrategyF-InKindSell317$3.09$979.53139,766
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---57,434
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---51,750
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---23,579
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---4,203
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---2,163
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---739
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell---215
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell6,519$15.63$101.89K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell32,559$14.45$470.48K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell19,935$8.03$160.08K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell81,000$2.51$203.31K-
Apr 29, 2024Cavorsi Robertofficer Vice President, StrategySell103,842$3.43$356.18K-
Apr 03, 2024Bilbo Patrickofficer Chief Operating OfficerF-InKindSell2,497$2.80$6.99K809,082
Apr 03, 2024Freedman Loriofficer Chief Admin. and Legal OfficerF-InKindSell1,974$2.80$5.53K469,272
Apr 03, 2024Grow Brianofficer Chief Commercial OfficerF-InKindSell1,977$2.80$5.54K520,809
Apr 03, 2024Montecalvo Antonio S.officer Vice President, Health PolicyF-InKindSell1,752$2.80$4.91K168,268
Apr 03, 2024Gillheeney Gary S.director, officer President and CEOF-InKindSell10,113$2.80$28.32K2,351,949
Mar 29, 2024Bilbo Patrickofficer Chief Operating OfficerM-ExemptBuy152,250$1.18$179.66K811,579
Mar 29, 2024Bilbo Patrickofficer Chief Operating OfficerM-ExemptSell152,250$1.18$179.66K-

The last insider sell of Organogenesis's stock was made by Cavorsi Robert on Jul 18 2024, selling 317 shares at $3.09 per share (valued at $979.53).

Organogenesis Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-1-
Q2 2024-17-
Q1 2024192382.61%
Q2 2023-7-
Q1 20231812150.00%
Q4 20222--
Q3 202221200.00%
Q2 2022235145.10%
Q1 20222110210.00%
Q4 2021225440.00%
Q3 20215683.33%
Q2 2021112152.38%
Q1 20212218122.22%
Q4 20201611600.00%
Q3 20201333.33%
Q2 20201611600.00%
Q1 202062300.00%
Q4 201921200.00%
Q3 20193113100.00%
Q2 20191--

0 total buy trades, and 1 total sell trades (buy/sell ratio of 0.00%) were made by Organogenesis's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024---
Q2 2024---
Q1 2024-4-
Q2 2023-2-
Q1 2023---
Q4 20222--
Q3 20222--
Q2 202232611.54%
Q1 2022-1-
Q4 202116--
Q3 20211333.33%
Q2 2021-12-
Q1 2021-18-
Q4 20201611600.00%
Q3 2020---
Q2 2020---
Q1 20204--
Q4 20191--
Q3 201930--
Q2 2019---

As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Organogenesis's stocks.

Organogenesis Peer Ownership


TickerCompany
RDHLRedHill Biopharma Ltd.
ITCIIntra-Cellular Therapies, Inc.
TKNOAlpha Teknova, Inc.
LFCRLifecore Biomedical, Inc.
GHSIGuardion Health Sciences, Inc.
DVAXDynavax Technologies Corporation
NBIXNeurocrine Biosciences, Inc.
ALIMAlimera Sciences, Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
PTPIPetros Pharmaceuticals, Inc.
DCPHDeciphera Pharmaceuticals, Inc.
ADMPAdamis Pharmaceuticals Corporation
LSDILucy Scientific Discovery Inc.
ALKSAlkermes plc
COLLCollegium Pharmaceutical, Inc.

ORGO Ownership FAQ


Organogenesis is owned by institutional shareholders (47.49%), insiders (32.88%), and public (19.63%). The largest institutional shareholder of Organogenesis is MORGAN STANLEY (8.78% of total shares) and the top mutual fund owner is SYNTAX ETF TRUST (0.67% of total shares).

Organogenesis's major institutional shareholders are MORGAN STANLEY, SOLEUS CAPITAL MANAGEMENT, L.P., BLACKROCK INC., ASSENAGON ASSET MANAGEMENT S.A., and VANGUARD GROUP INC. The top five shareholders own together 27.09% of the company's share outstanding.

As of Jun 2024, there are 116 institutional shareholders of Organogenesis.

MORGAN STANLEY owns 11.58M shares of Organogenesis, representing 8.78% of the company's total shares outstanding, valued at $32.41M (as of Jun 2024).

As of Jun 2024, SOLEUS CAPITAL MANAGEMENT, L.P holds 11.52M shares of Organogenesis (ORGO), compromising 8.74% of the company, valued at $32.25M.

BLACKROCK INC is the third largest holder of Organogenesis. The company owns 5.09M of the company's shares outstanding (worth $14.24M).